Laboratoires Thea

This phase 3 trial tests an experimental drug called sepofarsen in 32 people with Leber congenital amaurosis (LCA), a rare genetic condition that causes severe vision loss from birth. The drug is injected into one eye, while the other eye gets a placebo, to see if it safely impro…

This study tests a new eye drop called T1695 against an existing treatment (ciclosporin) for children aged 4 to 17 with moderate to severe vernal keratoconjunctivitis, a serious allergic eye condition. About 120 participants will use the drops for 4 weeks to see which better redu…

This study tests whether T10430 eye drops can safely slow or stop the progression of nearsightedness (myopia) in children aged 6 to 12. Myopia often starts in childhood and can lead to serious eye problems later in life. The trial will enroll 200 children to check for side effect…

This study looks at whether a new preservative-free eyelid cream helps people feel more comfortable after eyelid surgery. About 30 adults who are planning eyelid surgery will use the cream twice a day for 3 months. Researchers will measure how satisfied patients are with their ey…

This study is testing a new eye drop that combines trehalose, sodium hyaluronate, and NAAGA without preservatives. It will enroll 30 adults with dry eye disease who are either new to treatment or unhappy with their current drops. Over 6 months, researchers will track changes in s…

This study is testing a smart device called CONNECTDROP® that clips onto eye drop bottles to track how often glaucoma patients use their medication. About 200 adults with open-angle glaucoma will use the device and a smartphone app for one year. The goal is to see if the technolo…